Free Float -
Shares Float -
Shares Outstanding 870.032,00
PROSHARES ULTRA NASDAQ BIOTECHNOLOGIESLOGY ETF · US74347R2141 · BIB (FUND) ProShares · TER 1,19 % · United States · Financial Services — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PROSHARES ULTRA NASDAQ BIOTECHNOLOGIESLOGY
No Price
18.06.2026 20:00
Current Prices from PROSHARES ULTRA NASDAQ BIOTECHNOLOGIESLOGY
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 NASDAQ |
BIB
|
USD
|
18.06.2026 20:00
|
85,02 USD
| - |
 IEX |
BIB
|
USD
|
18.06.2026 19:55
|
84,93 USD
| - |
Share Float & Liquidity
Asset Allocation
| Asset | Percentage % |
|---|---|
| Equity | 67,95 % |
| Other | 5,02 % |
Largest Positions(274)
Updated on May 18 2026, 2:52 PM
| Symbol | ISIN | CUSIP | Name | Shares | Market Value | Percentage % |
|---|---|---|---|---|---|---|
| IQMM | US74350P6916 | 74350P691 | PROSHARES GENIUS MNY MKT ETF | 50.000 | 5,01 M EUR | 6,85 % |
| VRTX | US92532F1003 | 92532F100 | VERTEX PHARMACEUTICALS INC | 8.221 | 3,59 M EUR | 4,92 % |
| GILD | US3755581036 | 375558103 | GILEAD SCIENCES INC | 27.422 | 3,55 M EUR | 4,86 % |
| AMGN | US0311621009 | 031162100 | AMGEN INC | 10.523 | 3,43 M EUR | 4,70 % |
| REGN | US75886F1075 | 75886F107 | REGENERON PHARMACEUTICALS | 4.124 | 2,88 M EUR | 3,94 % |
| ALNY | US02043Q1076 | 02043Q107 | ALNYLAM PHARMACEUTICALS INC | 5.264 | 1,51 M EUR | 2,07 % |
| RVMD | US76155X1000 | 76155X100 | REVOLUTION MEDICINES INC | 7.866 | 1,15 M EUR | 1,57 % |
| BIIB | US09062X1037 | 09062X103 | BIOGEN INC | 5.825 | 1,12 M EUR | 1,54 % |
| UTHR | US91307C1027 | 91307C102 | UNITED THERAPEUTICS CORP | 1.740 | 989.329,20 EUR | 1,35 % |
| INSM | US4576693075 | 457669307 | INSMED INC | 8.556 | 933.801,84 EUR | 1,28 % |
Country Distribution
| Country | Percentage % |
|---|---|
| USA | 57,26 % |
| United Kingdom and Northern Ireland | 1,56 % |
| Netherlands | 1,43 % |
| Ireland | 1,20 % |
| France | 0,95 % |
| Germany | 0,55 % |
| Canada | 0,52 % |
| Switzerland | 0,27 % |
| Jersey (Kanalinsel) | 0,11 % |
| Other | 8,65 % |
Sector Distribution
| Sector | Percentage % |
|---|---|
| Healthcare | 64,66 % |
| Cash & Others | 28,17 % |
| Financial Services | 7,17 % |
Industry Distribution
| Industry | Percentage % |
|---|---|
| Biotechnology | 35,53 % |
| Medical - Pharmaceuticals | 13,26 % |
| Drug Manufacturers - General | 10,18 % |
| Medical - Diagnostics & Research | 2,86 % |
| Drug Manufacturers - Specialty & Generic | 1,76 % |
| Medical - Healthcare Information Services | 0,55 % |
| Medical - Instruments & Supplies | 0,11 % |
| Medical - Care Facilities | 0,05 % |
| Medical - Devices | 0,02 % |
| Other | 8,65 % |
Currency Distribution
| Currency | Percentage % |
|---|---|
| USD | 68,92 % |
| EUR | 4,05 % |
Company Profile for PROSHARES ULTRA NASDAQ BIOTECHNOLOGIESLOGY ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Fund Master Data
Issuer ProShares
Asset Class ETF
Name ProShares - Ultra Nasdaq Biotechnology
Asset Class Equity
Fund Currency USD
Total Expense Ratio (TER) 1,19 %
Domicile United States
Website proshares.com
Fund Key Figures
Fund Size 270.422,21 USD
NAV 82,35 USD
AUM 71,64 M USD
Avg. Daily Volume 10.305
Investment Strategy
The ProShares Ultra Nasdaq Biotechnology fund is structured to provide daily investment returns that effectively magnify the daily performance of the Nasdaq Biotechnology Index by two hundred percent (2x), all measured before accounting for any associated fees and expenses.
Updated on Jun 13 2026, 4:00 AM
Company Data
Name PROSHARES ULTRA NASDAQ BIOTECHNOLOGIESLOGY
Company ProShares Ultra Nasdaq Biotechnology
Symbol BIB
Primary Exchange 
Fondsgesellschaft
Fondsgesellschaft
ISIN US74347R2141
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 74 Mio
Country United States
Currency USD
Employees -
IPO Date 2010-04-09
Dividends from 'PROSHARES ULTRA NASDAQ BIOTECHNOLOGIESLOGY'
| Ex-Date | Dividend per Share |
|---|---|
| 25.03.2026 | 0,007 USD |
| 24.12.2025 | 0,13 USD |
| 24.09.2025 | 0,18 USD |
| 25.06.2025 | 0,17 USD |
| 26.03.2025 | 0,13 USD |
| 23.12.2024 | 0,40 USD |
| 25.09.2024 | 0,15 USD |
| 26.06.2024 | 0,26 USD |
| 20.03.2024 | 0,04 USD |
| 20.12.2023 | 0,04 USD |
Stock Splits
| Date | Split |
|---|---|
| 20.05.2015 | 2:1 |
| 24.01.2014 | 2:1 |
| 05.10.2012 | 2:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | BIB |
More Shares
Investors who hold PROSHARES ULTRA NASDAQ BIOTECHNOLOGIESLOGY also have the following shares in their portfolio:
